# Medical Spa Model See how treatment demand, memberships, pricing, and staffing shape a med spa's performance. - Canonical: https://finamodel.com/templates/med-spa - Excel download: https://finamodel.com/templates/med-spa.xlsx - Category: Healthcare - Model type: Operating model - Difficulty: Intermediate - Audiences: Investors & analysts, Founders & operators, Search-fund and PE buyers, Med-spa and aesthetics operators, Healthcare services investors, Lenders - Tags: med-spa, medical-aesthetics, aesthetics, rollup, dcf ## Overview This model helps you plan a medical aesthetics business across injectables, treatments, memberships, and skincare sales. It connects demand and pricing to injector capacity, staff costs, and the investment required to grow the platform. Use it to assess a single spa, a new location, or an acquisition strategy. The summary makes it clear how operating assumptions affect profit, cash flow, and value. ## What's included - Spa inputs: Year-1 spas, new spas per year, treatments per spa, providers per spa, average treatment ticket - Utilisation: Year-1 utilisation with an annual ramp and a practical ceiling - Service mix: injectables, laser and energy, body contouring and facials and skincare shares, per-tier price indices and net margins - Ancillary: members per spa and annual membership fee, skincare retail spend per treatment, price escalation - Cost structure: provider and support comp and wage with benefits and wage growth; facilities and device leases, marketing, technology and SG&A as % of gross profit; depreciation (% of revenue); tax - Capital and working capital: maintenance capex %, spa build-out cost per spa, NWC % of revenue growth, base-year revenue - Valuation: WACC, terminal growth, net debt, shares outstanding - Operations sheet: spa roll-forward, utilisation ramp, treatments per spa, total treatments, staff headcount, treatments per provider - Revenue sheet: four service tiers, treatment revenue, aesthetic memberships, skincare retail, total revenue - P&L sheet: revenue to net income with consumables and product cost, labour and overhead, margins, identity check - FCF sheet: NOPAT, depreciation add-back, capex, change in NWC, unlevered FCF, discount factor, PV - Valuation sheet: sum of PV, terminal value, enterprise value, equity value, value per share, implied EV/EBITDA - Dashboard with spas, treatments, utilisation, revenue per spa and per treatment, EBITDA margin, EV, per share, and revenue mix ## Medical Spa Financial Model: How the Template Values an Aesthetics Platform This med spa financial model template projects a multi-location medical aesthetics business over seven years, linking spa openings, treatment capacity, service mix and pricing to revenue, profit and unlevered free cash flow. It lets you examine how operational choices—from injector staffing to membership penetration—translate into EBITDA and enterprise value. ### Operating Drivers: Spas, Capacity and Volume The model begins with spa roll-forward and capacity utilisation. Each year, opening spas plus new openings equal closing spas, which drive provider count and treatment volume. - Mature treatments per spa are set by room and provider capacity, then multiplied by an effective utilisation factor. The seasoned utilisation curve starts at a Year 1 input and ramps annually to a practical ceiling, reflecting that no spa fills every slot. - A vintage-weighted blend discounts the year's new spas by a first-year productivity share, so de novo dilution from the build-out is charged upfront rather than pretending a new spa trades like a seasoned one. Demand-side volume is also capped by injector capacity—total providers times annual throughput per provider—keeping the staffing input honest. Injector and coordinator headcount scale with closing spas, and provider labour sits in operating expense rather than cost of revenue, reflecting the people-intensive, licence-gated nature of aesthetics. ### Calculation Flow: From Treatment Mix to Gross Profit Treatment revenue is built tier by tier: total treatments times each service tier's share times a blended average ticket times that tier's price index, escalated annually. The four tiers—injectables, laser and energy, body contouring, and facials and skincare—each carry distinct price indices and net margins, so the realised revenue per treatment and blended margin fall out of the mix rather than raw visit count. - For all tiers except injectables, consumables and product cost equals revenue times one minus net margin. Injectables product cost is instead built up from per-unit economics: toxin-led visits consume neurotoxin units at a cost per unit, filler-led visits consume HA syringes at a cost per syringe, blended by the visit split. - Aesthetic memberships and skincare retail add revenue but also carry their own costs—membership fees include a redemption credit, and skincare retail carries a product cost—so every revenue line is charged. The resulting gross profit then funds a headcount-driven labour stack and a gross-profit-geared overhead stack to reach EBITDA, EBIT and net income. ### Outputs: Dashboard, P&L and Valuation Metrics The model produces a one-page dashboard summarizing spas, treatments, utilisation, revenue per spa, revenue per treatment, total revenue, EBITDA, EBITDA margin, enterprise value and value per share. The P&L details revenue, consumables and product cost, gross profit and margin, provider and coordinator labour, overhead lines, EBITDA, EBIT, tax, net income and the implied injectables net margin that emerges from the per-unit build-up. - An identity check ensures the P&L balances. Unlevered free cash flow is NOPAT plus depreciation less maintenance capex, spa build-out capex and the change in working capital. - The DCF sums explicit UFCF and a Gordon-growth terminal value to enterprise value, subtracts net debt for equity value, and divides by shares for value per share. The dashboard also includes a seven-year operating summary, trend charts and a revenue-to-net-income waterfall. ### Practical Use: Testing Sensitivities and Business Relationships The template lets you flex key assumptions and observe how they flow through to valuation. Changing treatments per spa, the utilisation ramp, or the service mix shifts blended revenue per treatment, gross profit, EBITDA and enterprise value together. - Adjusting the toxin-led visit share, neurotoxin units per visit, cost per toxin unit, or syringes per filler visit directly moves injectables product cost and the implied tier margin. Altering members per spa, annual membership fee or retail spend per treatment affects the membership and skincare lines. - Because the model charges every revenue line with a cost and caps volume by injector capacity, it avoids overstating profit and reflects the operational trade-offs—such as slower build-out raising near-term volume per spa—that matter when evaluating growth strategies. ## Service mix drives the ticket and margin Revenue is the product of a spa estate, the treatments it fills, and the service mix of those treatments. The model makes spa count, treatments per spa, a utilisation ramp, and a four-tier service mix explicit, so total treatments and revenue per treatment are transparent operating metrics an analyst can flex against the cost stack rather than a top-down growth rate. ## Designed for one-edit responsiveness Every input, the spa pipeline, treatments per spa, the utilisation ramp, the service mix, the average ticket, the full cost stack, capex, working capital, and the WACC, is a named-range cell. Edit one and the operations build, revenue, P&L, free-cash-flow bridge, valuation, and dashboard all recompute. No formula rewrites are needed to test a pricing, mix, or expansion scenario. ## An unlevered DCF, not an EBITDA shortcut A med-spa group builds out and equips each location with capital-intensive devices, so the model bridges to unlevered free cash flow and discounts it at a WACC with a Gordon-growth terminal value. Enterprise value bridges through net debt to equity value and a per-share figure, and the implied EV/EBITDA falls out as a sanity check against where medical-aesthetics platforms change hands. ## Workbook structure ### Cover Workbook overview, sheet legend, units, and tab-colour key. - Title and scope framing - Sheet-by-sheet purpose summary - Units and tab-colour legend ### Assumptions Every driver in one sheet: spas, utilisation, service mix, costs, capital, valuation. - Year-1 spas, new spas per year, treatments per spa, providers per spa, average treatment ticket - Utilisation with an annual ramp and a practical ceiling - Service-tier shares, price indices and net margins, membership and retail inputs, price escalation - Provider and support comp and wage, the percent-of-gross-profit overhead lines, depreciation, tax - Maintenance capex, build-out cost per spa, NWC, base-year revenue - WACC, terminal growth, net debt, shares ### Operations Spas, treatments, utilisation, and staff. - Opening plus new spas equals closing spas - Utilisation ramps from a Year-1 input, capped at a ceiling - Treatments per spa equal mature treatments times utilisation - Total treatments equal closing spas times treatments per spa - Provider and support headcount equal closing spas times per-spa FTE - Treatments per provider as a productivity metric ### Revenue Revenue by service tier and ancillary. - Each tier equals total treatments times service share times average ticket times price index times escalation - Treatment revenue subtotal - Aesthetic memberships equal closing spas times members times annual fee - Skincare retail equals total treatments times retail spend per treatment - Total revenue ### P&L Revenue to net income. - Revenue from the Revenue sheet - Consumables and product cost as the inverse of the per-tier net margin - Gross profit and gross margin - Provider and support labour by headcount, the percent-of-gross-profit overhead stack - EBITDA, depreciation, EBIT, tax on positive EBIT, net income, margins, identity check ### FCF Unlevered free cash flow bridge. - EBIT and unlevered tax from the P&L - NOPAT equals EBIT less unlevered tax - Add back depreciation - Maintenance capex on revenue and build-out capex on new spas - Change in net working capital on revenue growth - Unlevered free cash flow - Discount factor and PV of UFCF ### Valuation Discounted cash flow. - Sum of PV of explicit UFCF - Gordon-growth terminal value and its PV - Enterprise value - Less net debt to equity value - Shares outstanding and value per share - Implied EV/EBITDA ### Dashboard Headline metrics and revenue mix. - Spas, treatments, utilisation, revenue per spa and per treatment - Revenue and EBITDA - EBITDA margin - Enterprise value and value per share - Revenue mix across treatments, memberships, and retail ## Features - **Service mix drives the ticket and margin:** Revenue is the product of a spa estate, the treatments it fills, and the service mix of those treatments. The model makes spa count, treatments per spa, a utilisation ramp, and a four-tier service mix explicit, so total treatments and revenue per treatment are transparent operating metrics rather than a top-down growth rate, and the high-ticket body-contouring-versus-facials spread is visible in the blend. - **Labour is the cost, and it is modelled as headcount:** Aesthetic medicine is a people-intensive, licence-gated business, so injector, esthetician and coordinator pay is the largest operating line and is built bottom-up from FTEs per spa, wage, benefits and wage inflation. Because provider labour sits in operating expense rather than cost of revenue, the gross margin runs high and the EBITDA margin is the meaningful profitability line, and the remaining overhead is geared to gross profit the way a real multi-site operator would expect. - **An unlevered DCF, not an EBITDA shortcut:** A med-spa group builds out and equips each location with capital-intensive devices, so EBITDA overstates cash. The model bridges EBITDA to cash through NOPAT, depreciation, maintenance and build-out capex, and the change in working capital, then discounts the unlevered free-cash-flow stream at a WACC with a Gordon-growth terminal value to a defensible enterprise and equity value. ## Use cases - **Intrinsic valuation:** Set the spa pipeline, utilisation ramp, service mix, the cost stack, and a WACC, and read the enterprise value, equity value, value per share, and implied EV/EBITDA. Sense-check the multiple against where medical-aesthetics platforms change hands. - **Roll-up and pipeline planning:** Flex new spas per year and the build-out cost per spa to see how the de novo and tuck-in pipeline consumes cash and lifts treatment volume, and watch revenue per spa and the EBITDA margin respond as the group scales. - **Mix and pricing stress test:** Shift the service mix toward higher-ticket device work or compress the per-tier net margins to model menu-pricing and consumable-cost pressure, and read the revenue-per-treatment, gross-margin, EBITDA-margin and valuation impact. ## Frequently asked questions ### What is a med-spa financial model? A med-spa financial model captures the seven-year operating economics and intrinsic value of a multi-location medical aesthetics group that runs injectables and laser treatments alongside body contouring, facials, recurring aesthetic memberships and a skincare retail attach. It rolls a spa count forward, converts a capacity-utilisation ramp into total treatments, prices treatments across a four-tier service mix at a blended average ticket and price index, runs the high-gross-margin injector-heavy cost stack to EBITDA, and discounts an unlevered free-cash-flow stream to enterprise value, equity value, and value per share. ### How is med-spa revenue built? Revenue is driven by the spa estate and its utilisation: total treatments equal closing spas times treatments per spa times a utilisation factor that ramps to a ceiling, and treatment revenue splits those treatments across an injectables, laser and energy, body contouring and facials and skincare mix, each priced at a blended average ticket times a per-tier price index. Spa-driven aesthetic memberships and treatment-driven skincare retail layer on to total revenue. ### Why is the service mix so important? A device-light injectables visit, a device-heavy laser session and a high-ticket body-contouring cycle each carry very different price points and consumable economics, so the realised ticket per treatment and the blended margin both fall out of the mix rather than the raw treatment count. The model makes the per-tier price indices and net margins explicit so an analyst can flex the mix and pricing and watch revenue per treatment, gross profit and EBITDA move together. ### Why an unlevered DCF instead of an EBITDA multiple? A med-spa group still builds out and equips each location with capital-intensive lasers and devices, so EBITDA overstates cash. The model bridges to unlevered free cash flow, NOPAT plus depreciation, less maintenance and build-out capex, less the change in working capital, and discounts it at a WACC, then adds a Gordon-growth terminal value. The implied EV/EBITDA falls out as a sanity check rather than as the valuation input. ## Related templates - [Dental Practice](https://finamodel.com/templates/dental-practice) - [Physical Therapy Clinic Model](https://finamodel.com/templates/physical-therapy) - [Franchise Unit Economics Model](https://finamodel.com/templates/franchise-model)